Literature DB >> 2053917

Arthritis in patients infected with human T lymphotropic virus type I. Clinical and immunopathologic features.

K Sato1, I Maruyama, Y Maruyama, I Kitajima, Y Nakajima, M Higaki, K Yamamoto, N Miyasaka, M Osame, K Nishioka.   

Abstract

Ten patients with chronic inflammatory arthropathy and the human T lymphotropic virus type I (HTLV-I) are described. These patients showed chronic persistent oligoarthritis, associated with proliferative synovitis, in large joints. The place of birth or residence of these patients was within the area endemic for adult T cell leukemia (ATL) and HTLV-I. The age at onset of articular symptoms tended to be higher in these patients than in typical rheumatoid arthritis patients. Anti-HTLV-I antibodies were detected in both sera and synovial fluids from all patients. Western blot analysis revealed antibodies to viral gag proteins (p19, p24, and p28). Atypical lymphocytes with nuclear indentations, consistent with ATL-like cells, were observed in both synovial fluid and synovial tissue. Furthermore, HTLV-I proviral DNA was integrated into the DNA of synovial fluid cells and synovial tissue cells. These findings suggest that HTLV-I might be involved in the pathogenesis of this unique arthropathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2053917     DOI: 10.1002/art.1780340612

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  21 in total

Review 1.  [Radiological differential diagnosis of rheumatoid arthritis].

Authors:  M C Wick; A S Klauser
Journal:  Radiologe       Date:  2012-02       Impact factor: 0.635

2.  Transmission of human T-cell leukemia virus type 1 to mice.

Authors:  J Fang; S Kushida; R Feng; M Tanaka; T Kawamura; H Abe; N Maeda; M Onobori; M Hori; K Uchida; M Miwa
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Lupus nephritis class I accompanied by tubulointerstitial nephritis with marked T-lymphocyte infiltration in an HTLV-1 positive patient.

Authors:  Toshiyuki Imasawa; Hiroshi Kitamura; Motonobu Nishimura; Takehiko Kawaguchi; Katsuyoshi Takata; Tadashi Yoshino; Yuichi Sugisaki
Journal:  CEN Case Rep       Date:  2012-11-03

4.  Treatment for HTLV-I associated arthropathy: a case study and synovial tissue culture analysis.

Authors:  Toshiaki Takahashi; Shigeki Takemoto; Katsuhito Kiyasu; Hiroshi Yamamoto; Toshikazu Tani; Isamu Miyoshi; Hirokuni Taguchi; Toshiaki Moriki; Emiko Miyazaki; Hideaki Enzan
Journal:  Rheumatol Int       Date:  2005-07-01       Impact factor: 2.631

5.  Synovial fluid T cells in HTLV-I positive RA.

Authors:  S Ijichi; I Maruyama; Y Maruyama; M Osame; T Matsuda; T Niinura; S Sonoda
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

6.  Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus).

Authors:  F Mortreux; M Kazanji; A S Gabet; B de Thoisy; E Wattel
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  High prevalence of arthropathy in HTLV-I carriers on a Japanese island.

Authors:  S Motokawa; T Hasunuma; K Tajima; A M Krieg; S Ito; K Iwasaki; K Nishioka
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

8.  Overgrowth of human synovial cells driven by the human T cell leukemia virus type I tax gene.

Authors:  T Nakajima; H Aono; T Hasunuma; K Yamamoto; I Maruyama; T Nosaka; M Hatanaka; K Nishioka
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

9.  HTLV-I env protein acts as a major antigen in patients with HTLV-I-associated arthropathy.

Authors:  Tomohiro Kato; Hiroshi Asahara; Manae Suzuki Kurokawa; Koushi Fujisawa; Tomoko Hasunuma; Hajime Inoue; Masanao Tsuda; Shigeru Takahashi; Satoru Motokawa; Takayuki Sumida; Kusuki Nishioka
Journal:  Clin Rheumatol       Date:  2004-06-15       Impact factor: 2.980

Review 10.  Retroviruses and autoimmune rheumatic diseases.

Authors:  J R Kalden; S Gay
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.